A new analysis provides a comprehensive update on this significant, and growing, cause of disability and death.
Understanding the Root Causes of Cognitive Decline in Disadvantaged Neighborhoods
Special Episode: FDA Approves Diazepam Buccal Film for Pediatric Seizures
Alzheon Initiates Open-Label Extensions for Phase 2 and 3 Studies of Alzheimer Agent ALZ-801
Episode 113: Lessons Learned in Alzheimer Drug Development
NeurologyLive and CMSC Announce the 3rd Annual Giants of MS Class of Inductees
NeuroVoices: Eoin P. Flanagan, MB, BCh, on the Potential Significance of Spinal Fluid Testing for MOGAD Diagnosis